Related Experiment Videos
[Infusion therapy for acute superior mesenteric artery occlusion]
Y Hatanaka1, C Takada, M Torashima
1Department of Radiology, Kumamoto National Hospital.
Summary
Transcatheter fibrolytic therapy effectively dissolved clots in two acute superior mesenteric artery occlusion cases. This minimally invasive approach shows promise for treating early-stage mesenteric artery blockages.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Thrombosis Treatment
Background:
- Acute superior mesenteric artery occlusion is a critical condition requiring rapid intervention.
- Traditional treatments carry significant risks and limitations.
- Early diagnosis and treatment are crucial for patient outcomes.
Observation:
- Transcatheter fibrolytic therapy was utilized in two early-stage acute superior mesenteric artery occlusion cases.
- A coaxial microcatheter was advanced into the superior mesenteric artery clot.
- Urokinase infusion was administered at 10,000 IU/min.
Findings:
- Complete clot dissolution was achieved rapidly following urokinase infusion.
- Dosages of 240,000 IU and 480,000 IU were effective in the two cases.
- The procedure was performed without any observed complications.
Implications:
- Transcatheter fibrolytic therapy offers a promising, minimally invasive treatment option for acute superior mesenteric artery occlusion.
- This technique may improve patient outcomes by enabling prompt reperfusion.
- Further research is warranted to establish standardized protocols and long-term efficacy.